Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Nightingale

Showing results (141-150 of 145) with videos related to

Pageof 15
Sort By:
You have reached the last page of results.This site can display upto 145 results.
Rheumatology (Oxford, England)|November 23, 2007
Sjögren's Systemic Clinical Activity Index (SCAI)--a systemic disease activity measure for use in clinical trials in primary Sjögren's syndromeS J Bowman, N Sutcliffe, D A Isenberg, et al.
Rheumatology (Oxford, England)|June 6, 2008
The Sjögren's Syndrome Damage Index--a damage index for use in clinical trials and observational studies in primary Sjögren's syndromeR J Barry, N Sutcliffe, D A Isenberg, et al.
British Journal of Haematology|November 28, 2008
Elevated FOSB-expression; a potential marker of valproate sensitivity in AMLFarhat L Khanim, Charlotte A Bradbury, Julie Arrazi, et al.
Nature|October 10, 1996
A massive phytoplankton bloom induced by an ecosystem-scale iron fertilization experiment in the equatorial Pacific OceanK H Coale, K S Johnson, S E Fitzwater, et al.
Arthritis Care & Research|May 31, 2014
Cardiovascular risk factors in women with primary Sjögren's syndrome: United Kingdom primary Sjögren's syndrome registry resultsM Juarez, T E Toms, P de Pablo, et al.
Pageof 15

Showing results (141-150 of 145) with videos related to

Sort By:
Pageof 15
You have reached the last page of results.This site can display upto 145 results.
Rheumatology (Oxford, England)|November 23, 2007
Sjögren's Systemic Clinical Activity Index (SCAI)--a systemic disease activity measure for use in clinical trials in primary Sjögren's syndromeS J Bowman, N Sutcliffe, D A Isenberg, et al.
Rheumatology (Oxford, England)|June 6, 2008
The Sjögren's Syndrome Damage Index--a damage index for use in clinical trials and observational studies in primary Sjögren's syndromeR J Barry, N Sutcliffe, D A Isenberg, et al.
British Journal of Haematology|November 28, 2008
Elevated FOSB-expression; a potential marker of valproate sensitivity in AMLFarhat L Khanim, Charlotte A Bradbury, Julie Arrazi, et al.
Nature|October 10, 1996
A massive phytoplankton bloom induced by an ecosystem-scale iron fertilization experiment in the equatorial Pacific OceanK H Coale, K S Johnson, S E Fitzwater, et al.
Arthritis Care & Research|May 31, 2014
Cardiovascular risk factors in women with primary Sjögren's syndrome: United Kingdom primary Sjögren's syndrome registry resultsM Juarez, T E Toms, P de Pablo, et al.
Pageof 15